Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE Prophylaxis in Hemophilia A
NCT02280265Unknown
- Sponsor
- Nanjing Medical University
- Start
- Nov 2014
- Primary completion
- Dec 2016
01
Overview
Open-label, single-arm trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Nanjing Medical University. Primary endpoint: Annual Bleeding Rate at 3 months. Status: unknown.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02280265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280265.